4th Antibody Engineering and Design Summit
|Event Date/Time: Jul 28, 2011||End Date/Time: Jul 30, 2011|
But who has the answers? The scientists we spoke to at Pfizer, MedImmune, Eli Lilly, Biogen Idec, Abbott & Merck (amongst others) think they know a few. Do you want a place alongside these experts to discuss challenges and share in their experiences? View the agenda pages here.
Building on the huge success of our previous Antibody Engineering & Design meetings, this industry gathering again brings together the perfect blend of world beating speakers, innovative technology developers and expert scientists to meet, learn, network and debate how to progress the field. Distinct from any big biologics show where topics range from discovery to market, we will be focussing only on the cutting-edge approaches designed to enhance therapeutic antibody potential.
Whatâ€™s covered on the agenda?
â€¢ Improving target discovery, antibody generation and lead isolation
â€¢ Lead optimization - Improving binding and in vivo antibody activity through engineering
â€¢ Innovative approaches to engineering affinity, stability, developability & more
â€¢ Using engineering to generate and optimize alternative antibody formats
â€¢ Novel technologies and research strategies to cut development timelines & costs
For more information please visit: www.antibody-engineering.com, email firstname.lastname@example.org or call us on +44 (0) 203 1418 700